Genus plc
 | |
| Public | |
| Traded as | LSE: GNS |
| Industry | Biotechnology |
| Founded | 1933 |
| Headquarters | Basingstoke, Hampshire, UK |
Key people |
Bob Lawson, Chairman[1] Karim Bitar, CEO[1] |
| Revenue | £398.5 million (2015)[2] |
| £59.5 million (2015)[2] | |
| £40.5 million (2015)[2] | |
| Website |
www |
Genus plc is a British-based business selling products manufactured using biotechnology to cattle and pig farmers. It is headquartered in Basingstoke and is a constituent of the FTSE 250 Index.
History
The business has its origins in the former Breeding & Production Division of the Milk Marketing Board which was established in 1933 and broken up in 1994.[3] In 1999 Genus acquired ABS Global, a company founded by J.R. Prentice in the US as the American Breeders Service in 1941 selling the semen of cattle.[4] In 2005 Genus acquired, through the takeover of Sygen International plc, PIC, a company founded by six pork producers in the UK as the Pig Improvement Company in 1962.[5]
Board of Directors
- Bob Lawson (Chairman)[1]
- Karim Bitar (CEO)
- Stephen Wilson (Group Finance Director)
- Nigel Turner (Senior Non-Executive Director)
- Mike Buzzacott (Non-Executive Director)
- Professor Duncan Maskell (Non-Executive Director)
- Lykele van der Broek (Non-Executive Director)
- Dan Hartley (Group General Counsel & Company Secretary)
Operations
The Company has two divisions:
References
- 1 2 3 "Genus plc - Investor Relations - Genus Board". genusplc.com. Retrieved 28 March 2015.
- 1 2 3 "Preliminary Results 2015". Genus plc. Retrieved 9 April 2016.
- ↑ The BSE Inquiry
- ↑ ABS Global Parent Reports Positive Year-End Results and Stock Listing
- ↑ "Genus Completes Acquisition Of Sygen". The Pig Site. Retrieved 28 March 2015.
External links
| companies |
| ||||||
|---|---|---|---|---|---|---|---|
| government and regulatory bodies |
| ||||||
| industry and professional bodies |
| ||||||
| books and journals | |||||||
| other | |||||||
 category | |||||||
|
This article is issued from Wikipedia - version of the 5/20/2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.